Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "EDS"

1383 News Found

Sigachi Industries unveils new products PureCoat and UltraMod
News | August 21, 2024

Sigachi Industries unveils new products PureCoat and UltraMod

Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential


Antara AGEasy celebrates one year of advancing senior health solutions
Healthcare | August 21, 2024

Antara AGEasy celebrates one year of advancing senior health solutions

AGEasy has made significant strides in addressing the pressing health concerns of seniors in India


Health Minister Nadda inaugurates ‘First Policy Makers’ Forum’ in New Delhi
News | August 20, 2024

Health Minister Nadda inaugurates ‘First Policy Makers’ Forum’ in New Delhi

These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance


Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
News | August 19, 2024

Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP

This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers


Zydus Lifesciences to scale up US specialties business
News | August 19, 2024

Zydus Lifesciences to scale up US specialties business

The company is also looking at an inorganic opportunity over the next two years to have a commercially ready footprint in the US


Aptar’s nasal unidose system delivers FDA-approved neffy
News | August 19, 2024

Aptar’s nasal unidose system delivers FDA-approved neffy

This marks the first regulatory approval worldwide for nasally-delivered epinephrine


HCAH Kolkata Center achieves NABH Certification
News | August 15, 2024

HCAH Kolkata Center achieves NABH Certification

Becomes the first rehab & recovery center in east India to earn NABH accreditation


Supriya Lifescience reports robust Q1 FY25 results with 21.7% revenue growth
News | August 13, 2024

Supriya Lifescience reports robust Q1 FY25 results with 21.7% revenue growth

European markets now contribute 51% of our business revenue up from 43% in Q4 FY24 and 34% in Q1 FY24


HealthCRED secures US$ 1.2 million in seed funding
Startup | August 13, 2024

HealthCRED secures US$ 1.2 million in seed funding

The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service